tiprankstipranks
Trending News
More News >

Livzon Pharmaceutical Group Schedules Board Meeting for Q1 Results Review

Story Highlights
Livzon Pharmaceutical Group Schedules Board Meeting for Q1 Results Review

Confident Investing Starts Here:

Livzon Pharmaceutical Group ( (HK:1513) ) has provided an announcement.

Livzon Pharmaceutical Group Inc. has announced a board meeting scheduled for April 23, 2025, to review and approve the company’s unaudited quarterly results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders and market positioning.

More about Livzon Pharmaceutical Group

Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is based in Zhuhai, China, and is involved in providing a range of healthcare solutions.

YTD Price Performance: -4.93%

Technical Sentiment Signal: Strong Sell

Current Market Cap: $4.1B

For a thorough assessment of 1513 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1